Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe (Q34469240)

2 August 2017

title

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe (English)

1 reference

2 August 2017

0 references

7

Claudia Kücherer

1 reference

Elisabeth Puchhammer-Stöckl

2 August 2017

30

Elisabeth Puchhammer-Stöckl

1 reference

2 August 2017

12

Claudia Balotta

0 references

Birgitta Åsjö

11

Birgitta Åsjö

1 reference

2 August 2017

Klaus Korn

21

0 references

Ana B. Abecasis

Ana B Abecasis

3

0 references

Maja Stanojevic

Maja Stanojevic

33

0 references

Leondios G Kostrikis

Leondios G Kostrikis

22

0 references

Ricardo Camacho

Ricardo J Camacho

14

0 references

Dimitrios Paraskevis

Dimitrios Paraskevis

27

0 references

Bonaventura Clotet Sala

15

Bonaventura Clotet

1 reference

2 August 2017

31

Anders Sönnerborg

1 reference

2 August 2017

4

Jan Albert

1 reference

Alicja Wiercińska-Drapało

2 August 2017

0 references

Mario Poljak

29

Mario Poljak

1 reference

2 August 2017

19

Andrzej Horban

1 reference

2 August 2017

1 reference

Matti Ristola

1 reference

Kristel Van Laethem

1 reference

Đorđe Jevtović

1 reference

Dan Otelea

26

Dan Otelea

1 reference

2 August 2017

5

Osamah Hamouda

1 reference

2 August 2017

8

Daniel Struck

1 reference

2 August 2017

10

Jurgen Vercauteren

1 reference

2 August 2017

Annemarie M J Wensing

35

Annemarie M J Wensing

1 reference

2 August 2017

16

Suzie Coughlan

1 reference

2 August 2017

18

Zehava Grossman

1 reference

2 August 2017

23

Kirsi Liitsola

1 reference

2 August 2017

24

Marek Linka

1 reference

2 August 2017

28

Roger Paredes

1 reference

2 August 2017

9

Jean-Claude Schmit

1 reference

2 August 2017

1

Dineke Frentz

1 reference

2 August 2017

13

Danail Beshkov

1 reference

2 August 2017

20

Tatjana Kolupajeva

1 reference

2 August 2017

32

Danica Stanekova

1 reference

2 August 2017

37

SPREAD Programme

1 reference

2 August 2017

34

Eric Van Wijngaerden

1 reference

David A. M. C. van de Vijver

2 August 2017

2

David A M C Van de Vijver

1 reference

2 August 2017

Louise B Jørgensen

6

1 reference

2 August 2017

Algirdas Griskevicius

17

1 reference

2 August 2017

Claus Nielsen

25

1 reference

2 August 2017

Charles A B Boucher

36

1 reference

2 August 2017

publication date

21 July 2014

1 reference

2 August 2017

published in

BMC Infectious Diseases

1 reference

2 August 2017

volume

14

1 reference

2 August 2017

page(s)

407

1 reference

Changes in first-line cART regimens and short-term clinical outcome between 1996 and 2010 in The Netherlands

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Limited cross-border infections in patients newly diagnosed with HIV in Europe

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Emergence of an HIV-1 cluster harbouring the major protease L90M mutation among treatment-naïve patients in Tel Aviv, Israel

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Evolutionary pathways of transmitted drug-resistant HIV-1.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Differential persistence of transmitted HIV-1 drug resistance mutation classes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Transmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Antiretroviral Therapies in Women after Single-Dose Nevirapine Exposure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Transmission of drug-resistant HIV-1 is stabilizing in Europe

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Better adherence with once-daily antiretroviral regimens: a meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Class-sparing regimens for initial treatment of HIV-1 infection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Transmission of drug-resistant HIV-1 in Europe remains limited to single classes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Minimizing resistance consequences after virologic failure on initial combination therapy: a systematic overview

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

An automated genotyping system for analysis of HIV-1 and other microbial sequences

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

MODELTEST: testing the model of DNA substitution

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223652

Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection.

6 July 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2334-14-407

Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2334-14-407

Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2334-14-407

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2334-14-407

An Empirical Test of Bootstrapping as a Method for Assessing Confidence in Phylogenetic Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2334-14-407

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2334-14-407

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2334-14-407

Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2334-14-407

Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2334-14-407

Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2334-14-407

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2334-14-407

The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2334-14-407

Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2334-14-407

Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection: Determinants and Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2334-14-407

Underestimation of HIV type 1 drug resistance mutations: results from the ENVA-2 genotyping proficiency program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2334-14-407

Transmitted Drug Resistant HIV-1 and Association With Virologic and CD4 Cell Count Response to Combination Antiretroviral Therapy in the EuroSIDA Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2334-14-407

Transmission networks of HIV-1 among men having sex with men in the Netherlands

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25047543

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2334-14-407

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference